News Archive

Browse historical market news and analysis from our daily reports

Life Sciences January 16, 2026

Policy shifts, M&A, and clinical wins reshape biotech and medtech outlook amid pricing and regulatory uncertainty.

Energy policy, auto supply-chain trade talks and a UK recycled rare-earth plant shift manufacturing supply dynamics.

Cross-border energy buyout, AI-data tuck-in, and distressed-deal litigation drive today’s M&A headlines.

CRE deal volume slips; multifamily leads transactions while foreclosures rise and policy changes threaten supply.

Retail braces for AI-driven change, M&A and bankruptcies, plus product collaborations boosting value-price offerings.

AI chip demand, TSMC expansion, data-access deals and AI tooling accelerate technology market dynamics.

Blockchain sees ETF inflows, tokenization momentum, stablecoin scrutiny and regulatory uncertainty shaping near-term trends.

TSMC and major banks beat estimates, but banks face policy risks that could pressure future earnings.

Governments tighten taxes and shift budget support amid fiscal pressure, revenue drives and political strains.

Mixed signals: banks and chipmakers beat estimates while trade, regulation, and consumer cracks cloud growth.

BoE edges toward future cuts, BOK holds, Indonesia intervenes; Fed independence faces political pressure.

Energy markets volatile as Iran airspace closure and rising U.S. inventories pressure oil; LNG deal and transport disruptions add strain.

Previous Page 4 of 77 Next